-
Apr 14, 2022, 18:54 PM
by
First-of-its-kind automated ultrasound platform now part of PerkinElmer portfolio aims to accelerate preclinical research
Full story
-
Apr 14, 2022, 18:54 PM
by
Full story
-
Apr 14, 2022, 18:54 PM
by
Watson-Marlow Fluid Technology Group - part of Spirax-Sarco Engineering plc, a FTSE 100 company - today announces it has changed its name to Watson-Marlow Fluid Technology Solutions (WMFTS). As the company evolves to meet the needs of the sectors in which it operates, following a successful period of global growth, the name change aligns with a strategic commitment to providing end-to-end fluid management solutions for customers.
Full story
-
Apr 14, 2022, 18:54 PM
by
Jennifer has more than 16 years’ commercial leadership experience in the diagnostics and life sciences industries.
Full story
-
Apr 14, 2022, 18:54 PM
by
Full story
-
Apr 14, 2022, 18:54 PM
by
Full story
-
Apr 14, 2022, 18:54 PM
by
Ripple Enterprise software to be deployed as part of the digital transformation in clinical
trials spearheaded by Curavit.
Full story
-
Apr 14, 2022, 18:54 PM
by
/ Rousselot®, Darling Ingredients’ health brand, and the global leader of collagen-based solutions announces the launch of GMP grade GelMA. X-Pure® GelMA is the first gelatin methacryloyl, or GelMA, on the market to be produced under GMP conditions.
Full story
-
Apr 14, 2022, 18:54 PM
by
BigOmics Analytics, a Swiss biodata analytics startup, announces raising additional funding from Eppendorf, a leading life science company that develops and sells instruments, consumables and services for liquid, sample and cell handling in laboratories worldwide. The additional funding brings the total amount raised so far to CHF 2.7M. It will be used to further develop BigOmics’ platforms, to expand its team and to grow its presence in the market.
Full story
-
Apr 14, 2022, 01:00 AM
by
User Not Found
Bio-IT World | Last month an international team of researchers published whole genome sequencing results comparing thousands of individuals with critical Covid-19 to a control group, discovering and replicating 23 independent variants that significantly predispose an individual to critical Covid-19. The exercise yielded fruit for very large scale whole genome sequencing projects as well.
Full story
-
Apr 13, 2022, 01:00 AM
by
User Not Found
Bio-IT World | The current data-rich era comes with a tremendous number of caveats. Large quantities of data are not necessarily high quality. Quality, in this case, can be used to describe the ease with which a user can obtain useful insights. Here we look at practices within a business that can maintain data integrity to prepare it for automated AI pipelines among other uses.
Full story
-
Apr 12, 2022, 01:00 AM
by
User Not Found
Bio-IT World | The way Jeanne Kehren sees it, pharma either has data graveyards, or “We are building data lakes without thinking about getting a boat.” Neither option advances the life sciences mission. As SVP and CIO at Bayer, Kehren is working toward a new vision of how pharma uses data, what it means to ask the right question, and how the healthcare industry as a whole can serve patients. COVID-19, she said, has been both a magnifier of some of our challenges and an opportunity.
Full story
-
Apr 11, 2022, 07:28 AM
by
User Not Found
Bio-IT World | Bio-IT World today announced the 2022 Innovative Practices Awards winners. Four grand prize awards were granted to AstraZeneca, Guardant Health with IQVIA, Merck KGaA, Darmstadt, Germany, with Genedata, and Quantum Leap Healthcare Collaborative / University of California San Francisco with OpenClinica. The awards ceremony will be held during the plenary program on Tuesday, May 3, at the 2022 Bio-IT World Conference & Expo in Boston.
Full story
-
Apr 7, 2022, 18:02 PM
by
Translational Genomics Research Institute (TGen), an affiliate of City of Hope, is using MemVerge Memory Machine Big Memory virtualization software to accelerate time to discovery for Idiopathic Pulmonary Fibrosis (IPF), a disease which affects 100,000 people annually in the U.S. Using MemVerge Big Memory technology, TGen is able to dramatically speed analytical processing by nearly 36% for single-cell RNA sequencing.
Full story
-
Apr 7, 2022, 18:02 PM
by
Ever since the launch of a wide range of glycerides in the first quarter of last year, there are increasing in-coming demands for glycerides from clients across the globe. To improve user experience, Alfa Chemistry announces to upgrade and optimize this product line by further diversifying the supply of different types of glycerides, including monoglycerides, diglycerides, triglycerides.
Full story
-
Apr 7, 2022, 18:02 PM
by
In a recent statement, the York-based CRO company CD Formulation announces the launch of tailored solutions for increased bioavailability excipients, which aims to tackle the issue of poor bioavailability, a long-lasting challenge in drug development.
Full story
-
Apr 7, 2022, 18:02 PM
by
Famed as a supplier of varieties of analytical reagents, Alfa Chemistry never let its customers down and always put customers’ concerns and needs in the first place. Hence, the company recently introduces environmental standards, which is a step to further diversify its offering of chromatography standards and also in response to the increasing needs for environmental analysis.
Full story
-
Apr 7, 2022, 18:02 PM
by
Canopy Launches Out of Stealth With $13 Million to Help Oncology Practices Adopt a Proactive Care Delivery Model
Full story
-
Apr 7, 2022, 18:01 PM
by
SciTech Development LLC, an oncology pharmaceuticals company, is pleased to announce its equity crowdfunding campaign on StartEngine.
Full story
-
Apr 7, 2022, 18:01 PM
by
MicrobioSeq represents the microbial genomics division of CD Genomics, headquartered in New York, USA. CD Genomics is a genomics service company with a good reputation for providing reliable de novo sequencing, genotyping, microarray, and bioinformatics services. With years of experience in the pharmaceutical and life science sectors, CD Genomics has announced Microbial Transcriptomics solutions, which hold promise in uncovering novel ways to treat disease and improve human health.
Full story